Alex Gorsky will step down as chief executive of Johnson & Johnson in January, ceding the role to longtime company executive Joaquin Duato, the health care giant announced Thursday.
Gorsky, the CEO since 2012, is stepping aside "due to family health reasons," according to a company press release, which said he will stay on as executive chairman.
Gorsky oversaw development of the company's one-shot Covid-19 vaccine. His tenure also coincided with a 60 percent increase in research and development, the company said.
He has also been at the helm during a recent settlement with US states over opioids, agreeing to pay up to $5 billion over nine years.
However, the company still faces litigation from plaintiffs who have sued J&J, alleging talcum products caused cancer.
Duato, currently the vice chairman of the company's executive committee, will also join the company's board of directors.
"I am honored to serve as Johnson & Johnson's next CEO," Duato said in the press release.
"As the world continues to face significant health challenges, including the ongoing pandemic, I am inspired by Johnson & Johnson's opportunity to play a key role in meaningfully improving the global trajectory of human health."
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Johnson & Johnson CEO to step down in April Manipur Chief Minister Slams Tejashwi Yadav Over "Racist" Jab At Himanta Sarma US Millionaire, Who Died By Suicide, Owed $34 Million With $8,000 In Bank On CCTV, Cops Seen Planting Drugs On Man In Mumbai, Suspended After Probe Celebrated "Russian Spy" Whale Hvaldimir Found Dead In Norway: Report Israeli Army Announces Death Of Soldier During Ongoing Raid In West Bank Ukraine Launched Overnight Drone Attack, Says Russia Amid Raging War Track Latest News Live on NDTV.com and get news updates from India and around the world.